| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.30B | -2.0% |
| Cost of Revenue | $35.74B | -0.3% |
| R&D Expense | $135.0M | +3.8% |
| SG&A Expense | $1.66B | +6.8% |
| Operating Income | $1.82B | -40.5% |
| Pre-tax Income | $1.60B | -39.0% |
| Income Tax | $240.0M | -52.1% |
| Net Income | $1.37B | -35.5% |
| EPS (Basic) | $4.16 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.38B | -0.4% |
| Short-term Investments | $2.61B | +7.3% |
| Inventory | $4.66B | -2.2% |
| Current Assets | $12.27B | -6.7% |
| Total Assets | $35.75B | -3.4% |
| Current Liabilities | $6.71B | -6.2% |
| Long-term Debt | $10.53B | +1.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.82B | -22.7% |
| Capital Expenditures | $1.84B | +20.1% |
| Investing Cash Flow | -$1.85B | -4.3% |
| Financing Cash Flow | -$1.90B | +2.8% |
| Free Cash Flow | $1.98B | -42.0% |
| -35.8% |
| EPS (Diluted) | $4.15 | -35.8% |
| Stockholders' Equity |
| $12.46B |
| -3.6% |